Skip to content Skip to footer
Subscribe Now
PharmaShots Magazine-April-2025 Edition
MAGAZINE

PharmaShots Magazine-April-2025 Edition

Emerging technologies holds a promising foothold in redefining the aspects of preventative, diagnostic, therapeutic, and patient care in the healthcare landscape. 3D Bioprinting offers innovative approach to addressing unmet healthcare needs with efficacious precision medicine in life-threatening conditions and developing therapies and medical devices that mimic complex human physiology.  In April, PharmaShots Magazine is exploring…
April 10, 2025

Read more

CXO TALKS

CXO Talks: Heba Nowyhed from Arcellx in a Candid Conversation with PharmaShots

CAR T-cell therapies hold a promising foothold in addressing unmet healthcare needs. Arcellx, a clinical-stage biotech company, is steadfastly exploring the potential of cell therapy in RRMM and generalized myasthenia gravis patients with its lead asset anito-cel. During presentations at ASH, anito-cel demonstrated no delayed neurotoxicity in both P-1 and pivotal P-II clinical trials for multiple myeloma.…
March 28, 2025

Read more

PharmaShots Magazine-March-2025 Edition
MAGAZINE

PharmaShots Magazine-March-2025 Edition

Did you know that 60 percent of pharmaceutical production is outsourced? As drug development costs rise, CDMOs have become safe havens for biopharma companies by offering scalable, cost-effective, and cutting-edge technology solutions for drug development and manufacturing.   In March, PharmaShots Magazine is navigating the evolving Biopharma CDMO frontier by decoding trends, illustrative infographics, thought-provoking articles,…
March 13, 2025

Read more

PharmaShots Magazine-February 2025 Edition
MAGAZINE

PharmaShots Magazine-February 2025 Edition

After successfully navigating the healthcare landscapes of the US, EU, and China, PharmaShots Magazine brings a comprehensive take on the Japanese Healthcare System. Japan ranked second in healthcare innovation owing to diverse positive parameters like advanced medical infrastructure, learned professionals, and more. In 2023, Japan allocated 11.4 percent of its GDP to enhancing healthcare capabilities.  …
February 13, 2025

Read more

Key Takeaways of J.P. Morgan Healthcare Conference 2025
INSIGHTS+

Key Takeaways of J.P. Morgan Healthcare Conference 2025

Shots:  The 43rd Annual J.P. Morgan Conference took place from 13th to 16th January in San Francisco, USA. J.P. Morgan Healthcare Conference serves as a pioneering hub that features presentations and dialogues on the advances of the healthcare industry by bringing healthcare professionals, researchers, manufacturers, and other healthcare stakeholders to one platform.   Innovation remained the…
January 28, 2025

Read more

PharmaShots Magazine-January 2025 Edition
MAGAZINE

PharmaShots Magazine-January 2025 Edition

For the past two months, we focused on US Healthcare and the European Healthcare systems. This month we are explored China’s Healthcare system by diving deep into the intricacies of government schemes, regulatory reforms, and trends and practices. In 2023, China spent around 5.4% of its GDP to boost healthcare services across its provinces.     In…
January 9, 2025

Read more

PharmaShots Magazine-December 2024 Edition
MAGAZINE

PharmaShots Magazine-December 2024 Edition

Do you know that several European countries offer European Health Insurance Cards that allow citizens to seek emergency care when they travel? European countries are widely regarded for their superior quality healthcare services. With most European countries offering Universal Coverage for primary care, this magazine aims to navigate the nuances of the European Healthcare System. …
December 11, 2024

Read more

CXO TALKS

CXO Talks: Jed Litwiniuk & Uwe Tigör from Auxilius Pharma in a Riveting Dialogue Exchange with PharmaShots

In this fifth episode of our recently launched CXO Talks, we spoke with a distinguished panel of speakers from Auxilius Pharma, Jed Litwiniuk, the CEO, and Uwe Tigör, the CMO of the company. Auxilius Pharma is an emerging specialized pharma company aimed at developing, optimizing, and delivering well-established medications internationally.   Jed & Uwe walked memory…
November 11, 2024

Read more

CXO TALKS

CXO Talks: Rashmi Gurnani from AKT Health Analytics in a Riveting Dialogue Exchange with PharmaShots

In the fourth reprise of our recently launched Complimentary Exclusive Video Interview, we have Rashmi Gurnani CEO of AKT Health Analytics. Rashmi sheds light on AKT’s distributor partnership with Certara, known for delivering global drug development solutions to pharmaceutical companies and CROs.  While discussing AKT’s role in assisting the US clients with Japan’s PMDA’s approval,…
October 14, 2024

Read more

Load more